日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Abnormally Activated MNX1 Promotes Tumor Growth and Osimertinib Resistance and Predicts Survival in EGFR-Mutant Lung Adenocarcinoma.

异常激活的 MNX1 促进肿瘤生长和奥希替尼耐药性，并预测 EGFR 突变型肺腺癌的生存期。

期刊:Drug Design Development and Therapy
影响因子:5.1
doi:10.2147/DDDT.S535214
Gu Weiguo, Gan Jinyu, Liu Penghui, Lai Jianfei, Liu Chaoxing, Zhang Guohua, Shi Chao, Jiang Qingkun, Qiu Feng
肺癌
肿瘤
EGF
EGFR
发表日期：2025
文献求助 收藏

Bridging the gap: how patient-derived lung cancer organoids are transforming personalized medicine

弥合差距：患者来源的肺癌类器官如何改变个性化医疗

期刊:Frontiers in Cell and Developmental Biology
影响因子:4.3
doi:10.3389/fcell.2025.1554268
Liu, Chaoxing; Shi, Chao; Wang, Siya; Qi, Rong; Gu, Weiguo; Yu, Feng; Zhang, Guohua; Qiu, Feng
3D/类器官
肺癌
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

MK2-mediated AKT/MYC signaling activation promotes epithelial-mesenchymal transition in lung adenocarcinoma.

MK2介导的AKT/MYC信号激活促进肺腺癌的上皮-间质转化。

期刊:Frontiers in Genetics
影响因子:2.8
doi:10.3389/fgene.2025.1615018
Qi Rong, Fang Chen, Liu Penghui, Gu Weiguo, Shi Chao, Zhang Guohua, Qiu Feng
肿瘤
肿瘤免疫
信号转导
MYC
AKT
发表日期：2025
文献求助 收藏

Development and Validation of a Prognostic Molecular Phenotype and Clinical Characterization in Grade III Diffuse Gliomas Treatment with Radio-Chemotherapy

放射化疗治疗III级弥漫性胶质瘤的预后分子表型及其临床特征的开发与验证

期刊:Therapeutics and Clinical Risk Management
影响因子:2.2
doi:10.2147/TCRM.S478905
Gu, Weiguo; Tang, Jiaming; Liu, Penghui; Gan, Jinyu; Lai, Jianfei; Xu, Jinbiao; Deng, Jianxiong; Liu, Chaoxing; Wang, Yuhua; Zhang, Guohua; Yu, Feng; Shi, Chao; Fang, Ke; Qiu, Feng
胶质瘤
发表日期：2025
文献求助 收藏

Mechanism of lncRNA WARS2-IT1 promoting angiogenesis of glioma through miR-299-3P/VEGFA axis and activating PI3K/AKT signaling pathway.

lncRNA WARS2-IT1 通过 miR-299-3P/VEGFA 轴和激活 PI3K/AKT 信号通路促进胶质瘤血管生成的机制

期刊:Cytotechnology
影响因子:1.7
doi:10.1007/s10616-025-00824-5
Hu Mingbin, Gu Weiguo, Huai Yajun, Wang Chunliang, Mei Jinhong
心血管
胶质瘤
PI3K/Akt
VEGF
血管生成
发表日期：2025
文献求助 收藏

Behavioral thermoregulation by reptile embryos promotes hatching success and synchronization

爬行动物胚胎的行为体温调节促进孵化成功和同步

期刊:Communications Biology
影响因子:5.2
doi:10.1038/s42003-023-05229-8
Shuo Liu, Bo Zhao, Xiaoting Gu, Weiguo Du
信号转导
发表日期：2023
文献求助 收藏

The prognosis of TP53 and EGFR co-mutation in patients with advanced lung adenocarcinoma and intracranial metastasis treated with EGFR-TKIs

TP53 和 EGFR 共突变对接受 EGFR-TKI 治疗的晚期肺腺癌伴颅内转移患者的预后影响

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2023.1288468
Gu, Weiguo; Liu, Penghui; Tang, Jiaming; Lai, Jianfei; Wang, Siya; Zhang, Jiaming; Xu, Jinbiao; Deng, Jianxiong; Yu, Feng; Shi, Chao; Qiu, Feng
肿瘤
肿瘤免疫
EGF
EGFR
P53
发表日期：2023
文献求助 收藏

Clinical Analysis of 50 Cases of Primary Pulmonary Lymphoma: A Retrospective Study and Literature Review

50例原发性肺淋巴瘤的临床分析：回顾性研究及文献综述

期刊:Technology in Cancer Research & Treatment
影响因子:2.8
doi:10.1177/15330338221075529
Hu, Mingbin; Gu, Weiguo; Chen, Shaoqing; Mei, Jinhong; Wang, Weijia
淋巴瘤
发表日期：2022
文献求助 收藏

A Competing Risk Nomogram for Predicting Cancer-Specific Death of Patients With Maxillary Sinus Carcinoma

用于预测上颌窦癌患者癌症特异性死亡的竞争风险列线图

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2021.698955
Hu, Mingbin; Li, Xiancai; Gu, Weiguo; Mei, Jinhong; Liu, Dewu; Chen, Shaoqing
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏

The Ki-67 Proliferation Index-Related Nomogram to Predict the Response of First-Line Tyrosine Kinase Inhibitors or Chemotherapy in Non-small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor-Mutant Status

Ki-67增殖指数相关列线图预测表皮生长因子受体突变型非小细胞肺癌患者对一线酪氨酸激酶抑制剂或化疗的反应

期刊:Frontiers in Medicine
影响因子:3
doi:10.3389/fmed.2021.728575
Gu, Weiguo; Hu, Mingbin; Xu, Linlin; Ren, Yuanhui; Mei, Jinhong; Wang, Weijia; Wang, Chunliang
肺癌
Ki-67
肿瘤
肿瘤免疫
信号转导
细胞生物学
发表日期：2021
文献求助 收藏